Roles of circulating soluble interleukin (IL)-6 receptor and IL-6 receptor expression on CD4+ T cells in patients with chronic hepatitis B

International Journal of Infectious Diseases

Volumn 15, Issue 4, 2011, Pages

  Zhang, Fan ^a,b   Yao, Simin ^b   Zhang, Mingxia ^b   Yuan, Jing ^b   Chen, Xinchun ^b   Zhou, Boping ^a,b  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

Author keywords

Chronic hepatitis B; Hepatitis B virus; Interleukin 6; Interleukin 6 receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 6 RECEPTOR; SOLUBLE INTERLEUKIN 6 RECEPTOR; UNCLASSIFIED DRUG; VIRUS DNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS LOAD;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-6; SOLUBILITY; YOUNG ADULT;

EID: 79952709719     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.12.008     Document Type: Article

References (25)

1. Rehermann B., Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005, 5:215-229.
2. Penna A., Del Prete G., Cavalli A., Bertoletti A., D'Elios M.M., Sorrentino R., et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997, 25:1022-1027.
3. Ren F., Hino K., Yamaguchi Y., Funatsuki K., Hayashi A., Ishiko H., et al. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection. J Med Virol 2003, 71:376-384.
4. Rincon M., Anguita J., Nakamura T., Fikrig E., Flavell R.A. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med 1997, 185:461-469.
5. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
6. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
7. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
8. Atreya R., Mudter J., Finotto S., Müllberg J., Jostock T., Wirtz S., et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 2000, 6:583-588.
9. Yamamoto M., Yoshizaki K., Kishimoto T., Ito H. IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 2000, 164:4878-4882.
10. Rose-John S., Scheller J., Elson G., Jones S.A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006, 80:227-236.
11. Rose-John S. Interleukin-6 biology is coordinated by membrane bound and soluble receptors. Acta Biochim Pol 2003, 50:603-611.
12. Kishimoto T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu Rev Immunol 2005, 23:1-21.
13. Mima T., Nishimoto N. Clinical value of blocking IL-6 receptor. Curr Opin Rheumatol 2009, 21:224-230.
14. Leon A.J., Gomez E., Garrote J.A., Bernardo D., Barrera A., Marcos J.L., et al. High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD. Mediators Inflamm 2009, 2009:580450.
15. Pizarro T.T., De La Rue S.A., Cominelli F. Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?. Gut 2006, 55:1226-1227.
16. Zhang J.Y., Zhang Z., Lin F., Zou Z.S., Xu R.N., Jin L., et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010, 51:81-91.
17. Vassilopoulos D., Rapti I., Nikolaou M., Hadziyannis E., Hadziyannis S.J. Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B. J Viral Hepat 2008, 15:817-826.
18. Wu W., Li J., Chen F., Zhu H., Peng G., Chen Z. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol 2010, 25:750-757.
19. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006, 177:739-747.
20. Heinz D., Peters M., Prange R., Gerken G., Rose-John S. Possible role of human interleukin-6 and soluble interleukin-6 receptor in hepatitis B virus infection. J Viral Hepat 2001, 8:186-193.
21. Hösel M., Quasdorff M., Wiegmann K., Webb D., Zedler U., Broxtermann M., et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 2009, 50:1773-1782.
22. Peters M., Blinn G., Jostock T., Schirmacher P., Meyer zum Büschenfelde K.H., Galle P.R., Rose-John S. Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. Gastroenterology 2000, 119:1663-1671.
23. Chen X., Zhang M., Liao M., Graner M.W., Wu C., Yang Q., et al. Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T cells. Am J Respir Crit Care Med 2010, 181:734-742.
24. Ge J., Wang K., Meng Q.H., Qi Z.X., Meng F.L., Fan Y.C. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 2010, 30:60-67.
25. Ye Y., Xie X., Yu J., Zhou L., Xie H., Jiang G., et al. Involvement of Th17 and Th1 effector responses in patients with hepatitis B. J Clin Immunol 2010, 30:546-555.